MX2009008488A - Forma estabilizadora de dosificacion oral de picoplatino. - Google Patents

Forma estabilizadora de dosificacion oral de picoplatino.

Info

Publication number
MX2009008488A
MX2009008488A MX2009008488A MX2009008488A MX2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A
Authority
MX
Mexico
Prior art keywords
dosage form
oral dosage
picoplatin
water
core
Prior art date
Application number
MX2009008488A
Other languages
English (en)
Spanish (es)
Inventor
Alistair J Leigh
Christopher A Procyshyn
Ernest S Y Wong
Christen M Giandomenico
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of MX2009008488A publication Critical patent/MX2009008488A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009008488A 2007-02-09 2008-02-08 Forma estabilizadora de dosificacion oral de picoplatino. MX2009008488A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US88968107P 2007-02-13 2007-02-13
PCT/US2008/001752 WO2008097661A1 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Publications (1)

Publication Number Publication Date
MX2009008488A true MX2009008488A (es) 2010-01-15

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008488A MX2009008488A (es) 2007-02-09 2008-02-08 Forma estabilizadora de dosificacion oral de picoplatino.

Country Status (12)

Country Link
EP (1) EP2114418A4 (zh)
JP (1) JP2010518089A (zh)
KR (1) KR20090109129A (zh)
CN (2) CN104288119A (zh)
AU (1) AU2008214202A1 (zh)
BR (1) BRPI0806418A2 (zh)
CA (1) CA2677640A1 (zh)
HK (1) HK1206267A1 (zh)
IL (1) IL200262A0 (zh)
MX (1) MX2009008488A (zh)
RU (1) RU2009133446A (zh)
WO (1) WO2008097661A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
EP2418955A4 (en) * 2009-04-15 2012-11-21 Poniard Pharmaceuticals Inc ORBIOTIC ANTICANCER THERAPY BASED ON HIGH BIODISIBILITY PICOPLATIN
AU2015263884B2 (en) * 2014-05-23 2019-11-14 Mingsight Pharmaceuticals, Inc. Treatment of autoimmune disease
CN107778331B (zh) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 一种甲啶铂的提纯方法
CN108864177B (zh) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2h3]-1-甲氨基-2-苯基丙烷的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
CN1434715A (zh) * 2000-02-16 2003-08-06 山之内制药株式会社 药物组合物
US20030021854A1 (en) * 2001-04-23 2003-01-30 Burrell Robert Edward Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
DE10141528B4 (de) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
US7691833B2 (en) * 2002-03-01 2010-04-06 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
JP2007529546A (ja) * 2004-03-18 2007-10-25 トランセイブ， インク． 吸入によるシスプラチンの投与
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
HK1206267A1 (zh) 2016-01-08
EP2114418A1 (en) 2009-11-11
WO2008097661A1 (en) 2008-08-14
RU2009133446A (ru) 2011-03-20
JP2010518089A (ja) 2010-05-27
CA2677640A1 (en) 2008-08-14
IL200262A0 (en) 2010-04-29
CN101678046A (zh) 2010-03-24
AU2008214202A1 (en) 2008-08-14
KR20090109129A (ko) 2009-10-19
CN104288119A (zh) 2015-01-21
EP2114418A4 (en) 2013-01-09
BRPI0806418A2 (pt) 2011-09-06

Similar Documents

Publication Publication Date Title
MX2009008488A (es) Forma estabilizadora de dosificacion oral de picoplatino.
MX2009008487A (es) Picoplatino encapsulado.
WO2009087634A3 (en) Methods and compositions for oral administration of insulin
NZ778023A (en) Colonic drug delivery formulation
WO2008132710A3 (en) Pharmaceutical nimodipine compositions
MX2012000217A (es) Sistema de suministro de farmacos que comprende polioxazolina y un agente bioactivo.
NZ600640A (en) Abuse-resistant formulations
MY173832A (en) Sintering powder
WO2011106416A3 (en) Abuse-resistant formulations
EA201071054A1 (ru) Твердый препарат, растворяющийся во рту
WO2010081443A3 (en) Dosage forms of tyrosine kinase inhibitors
EP2481402A3 (en) Nanoparticle comprising rapamycin and albumin as anticancer agent
WO2010064126A3 (en) Controlled release dosage forms
MX2014013826A (es) Composiciones farmaceuticas para la entrega de farmacos sustancialmente solubles en agua.
EP1832289A3 (en) Compositions and coatings for implantable medical devices
UA117685C2 (uk) Складена композиція для перорального введення, яка містить езетиміб та розувастатин
MX354416B (es) Formulaciones a base de nalbufina y sus usos.
MX349145B (es) Formulaciones orales y sales lipofilicas de metilnaltrexona.
TR201818761T4 (tr) 4-amino-5-floro-3-[6-(4-metilpiperazin-1-il)-1h-benzimidazol-2-il]-1h-kinolin-2-on laktat monohidrat içeren farmasötik bileşimler.
PH12014502191A1 (en) Capsule disintegrable in large-intestine-specific manner
WO2010002613A3 (en) Method of making a dry powder pharmaceutical composition
MX2013004579A (es) Composiciones orales que contienen microagregados.
EP3450395A3 (en) Graphene oxide nanoparticle compositions and methods of making the same
MX2013006417A (es) Composiciones para cuidado oral que comprende pigmentos perlescentes.
EP3391874A3 (en) Delivery devices containing encapsulated and/or particle- bound active pharmaceutical ingredients

Legal Events

Date Code Title Description
FA Abandonment or withdrawal